PDT Partners’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-21,432
| Closed | -$58.9K | – | 596 |
|
|
2023
Q2 | $58.9K | Sell |
21,432
-57,091
| -73% | -$157K | 0.01% | 545 |
|
|
2023
Q1 | $247K | Buy |
78,523
+21,151
| +37% | +$66.4K | 0.03% | 487 |
|
|
2022
Q4 | $338K | Buy |
57,372
+15,685
| +38% | +$92.5K | 0.05% | 458 |
|
|
2022
Q3 | $366K | Sell |
41,687
-66,376
| -61% | -$583K | 0.06% | 526 |
|
|
2022
Q2 | $815K | Buy |
+108,063
| New | +$815K | 0.07% | 456 |
|